AUTHOR=Briceño Pedro , Rivas-Yañez Elizabeth , Rosemblatt Mariana V. , Parra-Tello Brian , Farías Paula , Vargas Leonardo , Simon Valeska , Cárdenas César , Lladser Alvaro , Salazar-Onfray Flavio , Elorza Alvaro A. , Rosemblatt Mario , Bono María Rosa , Sauma Daniela TITLE=CD73 Ectonucleotidase Restrains CD8+ T Cell Metabolic Fitness and Anti-tumoral Activity JOURNAL=Frontiers in Cell and Developmental Biology VOLUME=9 YEAR=2021 URL=https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2021.638037 DOI=10.3389/fcell.2021.638037 ISSN=2296-634X ABSTRACT=
CD39 and CD73 are ectoenzymes that dephosphorylate ATP into its metabolites; ADP, AMP, and adenosine, and thus are considered instrumental in the development of immunosuppressive microenvironments. We have previously shown that within the CD8+ T cell population, naïve and memory cells express the CD73 ectonucleotidase, while terminally differentiated effector cells are devoid of this enzyme. This evidence suggests that adenosine might exert an autocrine effect on CD8+ T cells during T cell differentiation. To study the possible role of CD73 and adenosine during this process, we compared the expression of the adenosinergic signaling components, the phenotype, and the functional properties between CD73-deficient and WT CD8+ T cells. Upon activation, we observed an upregulation of CD73 expression in CD8+ T cells along with an upregulation of the adenosine A2A receptor. Interestingly, when we differentiated CD8+ T cells to Tc1 cells